top of page

Home > Specialists > Neurosurgery > Dr. Tao Jiang (江涛)

Dr. Shijing Deng - Ophthalmologist - Beijing Tongren Hospital Beijing

Specialty & Clinical Focus:

Neurosurgery specialist at Beijing Tiantan Hospital in Beijing, with a clinical focus on glioma surgery, molecular-pathology-guided glioma treatment, functional-area protection, and complex intracranial tumors including meningioma, schwannoma, brain metastases, pituitary adenoma, primary intracranial lymphoma, and germ cell tumors.

Professional Title & Qualifications:

  • Academician of the Chinese Academy of Engineering,

  • Chief Physician,

  • Professor,

  • Doctoral Supervisor

Hospital & Department：

Beijing Tiantan Hospital, Capital Medical University – Department of Neurosurgery

(address: No. 119 South Fourth Ring West Road, Fengtai District, Beijing, 100070)

Dr. Tao Jiang (江涛) - Neurosurgery Specialist

Personal Biography

Dr. Tao Jiang is a neurosurgeon, Chief Physician, Professor, Doctoral Supervisor, and Academician of the Chinese Academy of Engineering. He is affiliated with Beijing Tiantan Hospital and has focused extensively on neurosurgical oncology, glioma surgery, and molecular-pathology-guided brain tumor research.

Dr. Jiang earned his Master's and Ph.D. degrees in neurosurgery from Harbin Medical University between 1991 and 1996. He later completed postdoctoral research at Beijing Tiantan Hospital under Dr. Wang Zhongcheng, followed by postdoctoral work in neuro-oncology at MD Anderson Cancer Center at the University of Texas from 2002 to 2004.

As of late 2023, the source page reports that Dr. Jiang had acted as the primary surgeon for over 7,000 clinical procedures. His clinical and research work emphasizes glioma surgery, preservation of neurological function, genomic research, the Chinese/Asian Glioma Genome Atlas (CGGA/AGGA), and the development of molecular-pathology-based treatment approaches for glioma patients.

Why Choose Dr. Tao Jiang?

Dr. Tao Jiang’s clinical practice is grounded in molecular pathology and precision medicine for neurosurgical oncology. For international patients facing complex glioma diagnoses, this background can be especially relevant when prior imaging, pathology reports, molecular testing results, treatment history, and surgical questions need to be organized for specialist review. A central feature of Dr. Jiang’s surgical work is the protection of neurological function during brain tumor surgery. His experience with awake craniotomy techniques, motor-area protection, and multilingual language-area mapping is particularly relevant for patients whose tumors are close to functional brain regions. 


As Director of the Neurosurgery Center at Beijing Tiantan Hospital and a researcher involved in glioma genomics, Dr. Jiang combines high-volume neurosurgical exposure with molecular-pathology-informed clinical research. This makes his profile especially relevant for patients seeking a structured glioma surgery second opinion in China before considering international travel.

Pre-Travel Case Review & Specialist Liaison

For international patients facing a complex glioma or intracranial tumor diagnosis, a pre-travel specialist-review pathway can help organize the key materials needed before deciding whether to pursue care in Beijing. MedBridgeNZ coordinates medical-record preparation, translation coordination, client-authorized document transfer, and appointment request communication with the relevant third-party hospital or specialist office where available.


Submitted imaging, pathology reports, molecular testing results, treatment history, and clinical questions will be used by the relevant hospital or specialist office for appointment triage or preliminary case-screening where available. This process helps patients prepare more clearly for possible next steps in China while keeping clinical opinions and treatment decisions with the hospital or licensed specialist.

Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.

Secure a Remote Case Review with

Dr. Tao Jiang

Areas of Expertise

  • Surgical treatment of neurosurgical diseases and glioma.

  • Personalized comprehensive treatment of glioma guided by molecular pathology.

  • Surgery and chemotherapy for intracranial tumors, including meningioma, schwannoma, primary intracranial lymphoma, germ cell tumors, brain metastases, and pituitary adenoma.

Verified Client Satisfaction Metrics

⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating

* Treatment Pathway Satisfaction:

5.0/5.0

* Communication & Professionalism:

5.0/5.0

* High demand: Chosen online for specialist liaison and case reviews by over:

6,500 clients

(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)

Work Experience

  • Director of the Neurosurgery Center, Beijing Tiantan Hospital.

  • Director of the Beijing Neurosurgical Institute.

  • Vice Dean of the Neurosurgery Faculty, Capital Medical University.

  • Deputy Director of the National Center for Neurological Disorders.

Education & Training

  • Master's and Ph.D. degrees in neurosurgery from Harbin Medical University between 1991 and 1996.

  • Postdoctoral research at Beijing Tiantan Hospital under the mentorship of Dr. Wang Zhongcheng.

  • Postdoctoral researcher in neuro-oncology at MD Anderson Cancer Center at the University of Texas in the United States from 2002 to 2004.

Awards & Honors

  • Top 10 Advances in Life Sciences in China (2018).

  • National Science and Technology Progress Award (Second Class, as first completer).

  • Provincial and Ministerial Award (First Class, three times).

  • 14th Guanghua Engineering Science and Technology Award.

  • Outstanding Communist Party Member of the Beijing Health System.

  • Beijing Advanced Worker.

  • Beijing Scholar (2019).

  • Led the glioma precision diagnosis and treatment team to be awarded the Beijing Worker Pioneer title (2022).

Academic & Professional Memberships

  • First Chairman of the Glioma Professional Committee of the Chinese Medical Doctor Association and the Chinese Anti-Cancer Association.

  • President of the Beijing Medical Science and Health Society.

  • Chairman of the Asian Glioma Genome Atlas Project.

  • Chinese Chairman of Global Glioma Clinical Trial Projects.

  • Group Leader in the Chinese Medical Association.

  • Chief Editor of "Nervous Diseases and Mental Health".

  • Deputy Chief Editor of "Journal of Clinical Surgery", "China Clinical Practical Medicine", and "Cancer Biology & Medicine".

  • Member of the Academic Advisory Committee of the Chinese Academy of Medical Sciences.

Research & Publications

  • Established a multi-dimensional omics database for glioma.

  • Conducted molecular pathology research on glioma and introduced molecular subtyping into glioma classification prior to the WHO classification.

  • Identified the fusion gene PTPRZ1-MET and developed the targeted drug PLB-1001, with findings published in Cell.

  • Implemented awake craniotomy techniques and established a motor area protection technology system in China.

  • Developed a multilingual language area precise positioning and protection plan, and created a staged resection surgical approach for language-functional area glioma.

  • Published 362 papers in scientific journals such as Cell and PNAS as the corresponding author, with 10 cover articles, 15,700 citations, and an H-index of 66.

  • Led the formulation of multiple diagnosis and treatment guidelines and norms, including the "Glioma Diagnosis and Treatment Norms" and "Glioma Diagnosis and Treatment Guidelines" for the National Health Commission.

  • Holds one Class III medical device registration certificate and 25 domestic and international patents.

Selected Peer-Reviewed Publications

Below is a selection of Dr. Jiang's highly cited clinical research, demonstrating ongoing leadership in the treatment and diagnostic evaluation of complex conditions:

  • Wu, L., et al. (2022). Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma. Cancer Discovery. Read on PubMed (PMID: 36122307)

  • Fang, S., et al. (2021). Tumor location-based classification of surgery-related language impairments in patients with glioma. Journal of Neuro-Oncology. Read on PubMed (PMID: 34599481)

  • Fang, S., et al. (2020). Awake craniotomy for gliomas involving motor-related areas: classification and function recovery. Journal of Neuro-Oncology. Read on PubMed (PMID: 32350781)

*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.

Frequently Asked Questions (FAQs)

How can I request remote specialist-review coordination with Dr. Jiang if I am outside China?


You do not need to travel to Beijing for the first stage of preparation. MedBridgeNZ can coordinate medical-record organization, translation coordination, client-authorized imaging and document transfer, and appointment request communication with Dr. Jiang’s department or the relevant specialist office where available. This helps your existing case materials be prepared for specialist appointment triage or preliminary case-screening before you consider international travel.


Is my type of brain tumor within Dr. Jiang’s clinical focus?


Dr. Jiang’s visible clinical focus includes glioma surgery, molecular-pathology-guided glioma treatment, and the surgical and comprehensive treatment of intracranial tumors including meningioma, schwannoma, primary intracranial lymphoma, germ cell tumors, brain metastases, and pituitary adenoma. MedBridgeNZ can help prepare and submit your available records for third-party specialist-office triage where available, but clinical suitability is determined by the relevant medical professionals.


If an in-person pathway at Beijing Tiantan Hospital may be appropriate, what support can MedBridgeNZ provide?


If the relevant clinical team indicates that an in-person pathway may be considered, MedBridgeNZ can assist with appointment request coordination, medical invitation or visa-document coordination support, translation coordination, travel and accommodation planning support, and non-clinical bilingual administrative support during hospital visits. Appointment availability, hospital processes, and clinical decisions remain with the relevant hospital and licensed medical professionals.


What makes Dr. Jiang’s approach to glioma surgery distinctive?


Dr. Jiang’s work integrates molecular pathology, glioma genomics, and neurosurgical techniques focused on protecting motor and language-related brain functions. His experience includes awake craniotomy techniques, functional-area protection, and molecular-pathology-informed glioma research. For patients comparing specialist options, these factors can make a structured records review and pre-travel case preparation process especially useful.


Flexible Ways to Connect with the Specialist

We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:

  • Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.

  • On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.

  • In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.

How MedBridgeNZ Helps You:

MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. For patients considering Dr. Tao Jiang or Beijing Tiantan Hospital, we help with appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis or treatment, and third-party medical or travel costs remain separate unless expressly stated in writing.

bottom of page